Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
RXO Inc (NYSE: RXO) closed the day trading at $12.58 down -4.98% from the previous closing price of $13.24. In other words, the price has decreased by -$4.98 from its previous closing price. On the day, 7.17 million shares were traded. RXO stock price reached its highest trading level at $13.03 during the session, while it also had its lowest trading level at $12.19.
Ratios:
For a better understanding of RXO, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.26 and its Current Ratio is at 1.26. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.35.
On March 13, 2025, Truist started tracking the stock assigning a Buy rating and target price of $24.
On March 07, 2025, Deutsche Bank started tracking the stock assigning a Hold rating and target price of $19.Deutsche Bank initiated its Hold rating on March 07, 2025, with a $19 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 12 ’24 when Nettles Michelle bought 1,800 shares for $27.89 per share. The transaction valued at 50,202 led to the insider holds 15,185 shares of the business.
MFN Partners, LP bought 10,266,810 shares of RXO for $207,492,230 on Aug 12 ’24. The 10% Owner now owns 27,577,666 shares after completing the transaction at $20.21 per share. On May 09 ’24, another insider, MFN Partners, LP, who serves as the 10% Owner of the company, bought 61 shares for $20.39 each. As a result, the insider paid 1,244 and bolstered with 17,310,856 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RXO now has a Market Capitalization of 2170175744 and an Enterprise Value of 2683662592. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.45 while its Price-to-Book (P/B) ratio in mrq is 1.27. Its current Enterprise Value per Revenue stands at 0.59 whereas that against EBITDA is 22.937.
Stock Price History:
The Beta on a monthly basis for RXO is 1.81, which has changed by -0.36815673 over the last 52 weeks, in comparison to a change of 0.017286062 over the same period for the S&P500. Over the past 52 weeks, RXO has reached a high of $32.82, while it has fallen to a 52-week low of $12.39. The 50-Day Moving Average of the stock is -31.31%, while the 200-Day Moving Average is calculated to be -50.25%.
Shares Statistics:
Over the past 3-months, RXO traded about 1.55M shares per day on average, while over the past 10 days, RXO traded about 2339660 shares per day. A total of 162.52M shares are outstanding, with a floating share count of 160.63M. Insiders hold about 2.00% of the company’s shares, while institutions hold 104.58% stake in the company. Shares short for RXO as of 1743379200 were 9192014 with a Short Ratio of 5.93, compared to 1740700800 on 7763025. Therefore, it implies a Short% of Shares Outstanding of 9192014 and a Short% of Float of 15.7.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The dynamic stock of RXO Inc (RXO) is currently being evaluated by a team of 18.0 analysts, each contributing to its current rating.The consensus estimate for the next quarter is $0.04, with high estimates of $0.08 and low estimates of -$0.01.
Analysts are recommending an EPS of between $0.43 and $0.11 for the fiscal current year, implying an average EPS of $0.23. EPS for the following year is $0.57, with 20.0 analysts recommending between $0.97 and $0.39.
Revenue Estimates
14 analysts predict $1.49B in revenue for the current quarter. It ranges from a high estimate of $1.6B to a low estimate of $1.42B. As of the current estimate, RXO Inc’s year-ago sales were $913MFor the next quarter, 14 analysts are estimating revenue of $1.55B. There is a high estimate of $1.65B for the next quarter, whereas the lowest estimate is $1.46B.
A total of 18 analysts have provided revenue estimates for RXO’s current fiscal year. The highest revenue estimate was $6.9B, while the lowest revenue estimate was $5.98B, resulting in an average revenue estimate of $6.46B. In the same quarter a year ago, actual revenue was $4.55BBased on 18 analysts’ estimates, the company’s revenue will be $6.93B in the next fiscal year. The high estimate is $7.55B and the low estimate is $6.16B.
